Trailing-twelve-month (TTM) revenue is $2.85 Billion with a year-over-year growth of (3.04%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $754,177,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q3 FY2026Period ended 2025-12-31 | $861,288,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-09 |
| Q4 FY2026Period ended 2026-03-31 | $715,243,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-01 |
| Q1 FY2027Period ended 2026-06-30 | $523,779,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $2,854,487,000 |
Current P/S: $1,058,594,479 market capitalization ÷ $2,854,487,000 TTM revenue = 0.37x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $523.78M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:16:15.396Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Food Ingredient Sales | N/A | $251M | $294M | $292M | $321M | $331M |
| Manufactured Product, Other | $1.7B | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| All Other Countries | $858M | $851M | $893M | $899M | $823M | $809M |
| BELGIUM | $366M | $283M | $396M | $552M |
$2.85B
$2.85 Billion
(3.04%)
vs. $2.94B a year ago (TTM)
+7.19%
5 Year compound annual growth rate
1 Year
(3.04%)
3 Year
+2.41%
5 Year
+7.19%
10 Year
+2.92%
15 Year
+0.86%
20 Year
(1.15%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.92B | ($22.81M) | (0.77%) |
| 2025 | $2.95B | +$198.71M | +7.23% |
| 2024 | $2.75B | +$178.75M | +6.96% |
| 2023 | $2.57B | +$466.22M | +22.16% |
| 2022 | $2.10B | +$120.24M | +6.06% |
| 2021 |
TTM Growth
(3.04%)
3-Year CAGR
+2.41%
5-Year CAGR
+7.19%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-26T00:16:15.396Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Product and Service, Other | $50M | $60M | $84M | $78M | $67M | $119M |
|---|
| Service, Other | $73M | $77M | $78M | $83M | $74M | $75M |
|---|
| Tobacco Sales | N/A | $1.7B | $2.1B | $2.3B | $2.5B | $2.4B |
|---|
| $560M |
| CHINA | $53M | $98M | $204M | $220M | $294M | $169M |
|---|
| EGYPT | N/A | N/A | N/A | N/A | $144M | N/A |
|---|
| FRANCE | N/A | N/A | $65M | $17M | $23M | $41M |
|---|
| GERMANY | $95M | $93M | $109M | $95M | $116M | $66M |
|---|
| INDONESIA | N/A | N/A | N/A | $117M | $106M | $194M |
|---|
| ITALY | N/A | N/A | N/A | N/A | N/A | $52M |
|---|
| MEXICO | $51M | $45M | $52M | $26M | $29M | $23M |
|---|
| NETHERLANDS | N/A | N/A | $52M | $42M | $38M | $29M |
|---|
| PHILIPPINES | $94M | $148M | $150M | $134M | $121M | $152M |
|---|
| POLAND | $97M | $90M | $120M | $98M | $100M | $171M |
|---|
| UNITED STATES | $369M | $495M | $530M | $548M | $622M | $659M |
|---|
| $1.98B |
| +$73.38M |
| +3.84% |
| 2020 | $1.91B | ($317.17M) | (14.24%) |
| 2019 | $2.23B | +$193.21M | +9.50% |
| 2018 | $2.03B | ($37.27M) | (1.80%) |
| 2017 | $2.07B | ($49.16M) | (2.32%) |
